VAN ECK ASSOCIATES CORP - AEVI GENOMIC MEDICINE INC ownership

AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 80 filers reported holding AEVI GENOMIC MEDICINE INC in Q4 2016. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of AEVI GENOMIC MEDICINE INC
ValueSharesWeighting
Q3 2017$21,000
-4.5%
17,054
+4.7%
0.00%
Q2 2017$22,000
-18.5%
16,293
+12.8%
0.00%
Q1 2017$27,000
-64.0%
14,4470.0%0.00%
Q4 2016$75,00014,4470.00%
Other shareholders
AEVI GENOMIC MEDICINE INC shareholders Q4 2016
NameSharesValueWeighting ↓
Birchview Capital, LP 128,000$257,0000.17%
Baker Brothers Advisors 4,055,142$8,151,0000.07%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,500,000$11,055,0000.03%
Verity Asset Management, Inc. 10,000$20,0000.02%
OneDigital Investment Advisors LLC 10,850$22,0000.01%
Legacy Advisors, LLC 2,450$4,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 87,382$176,0000.00%
HYMAN CHARLES D 15,143$30,0000.00%
Wealthcare Advisory Partners LLC 5,000$10,0000.00%
Kavar Capital Partners, LLC 1,500$3,0000.00%
View complete list of AEVI GENOMIC MEDICINE INC shareholders